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We analyzed the sequence of nef genes from different tissues of three rhesus macaques that had been infected with
molecularly cloned SIVmac239 for 88 to 92 weeks. Comparison of the predicted amino acid sequences revealed that each
macaque had selected out specific amino acid substitutions and that most of this variation (70%) was confined to four
regions, amino acids 39 to 75, 90 to 105, 153 to 167, and 191 to 217, comprising 36% of the protein. The nef genes in these
animals underwent extensive genetic variation with average nucleotide and amino acid substitution rates varying from 0.86
to 2.84% and 2.47 to 6.27%, respectively, although tissue-specific selection of nef variants occurred in only 1 of 14 tissues
examined in this study. Comparison of the rate of nucleotide and amino acid substitutions in the nef genes to those previously
reported in the env in the central nervous system (CNS) and lymph node (LN) revealed that the predicted amino acid
substitution rates for Nef were much higher than for the gp120 region of env in the CNS and LN tissues for one macaque.
In the two other macaques, the predicted amino acid substitution rates were similar between these two proteins in LN
tissues, but the amino acid substitution rates in Nef were significantly higher than in the gp120 from the CNS. Comparison
of the nucleotide substitutions in the region of overlap between the env and the nef revealed that approximately 83% of the
nucleotide substitutions in this area resulted in a Nef amino acid sequence change, 26% of the nucleotide substitutions
resulted in a gp41 amino acid change, and 9.5% of nucleotide substitutions resulted in amino acid sequence changes in
both proteins, suggesting a preference for the selection of amino acid substitutions in the Nef in these animals. Our results
indicate that in animals infected with SIVmac239 for prolonged periods, variation in the nef occurs at rates similar to or
exceeding that observed for the env gene. q 1996 Academic Press, Inc.
The genomic organization of the primate lentiviruses virus replication (16, 24) and may act at the level of stimu-
lation of proviral synthesis (22). More recent studies indi-(HIV-1, HIV-2, and SIV) differs from the ungulate and fe-
line lentiviruses by the presence of a nef gene at the 3* cate that Nef is involved in the activation of resting lym-
phocytes in the host, since the introduction of small num-end of the envelope glycoprotein gene (5, 17). The nef
gene of HIV-1 codes for a 27-kDa membrane bound pro- bers of specific mutations in the nef gene resulted in a
virus that had mitogenic effects in T cells and causedtein that is both myristylated and phosphorylated (2, 10,
11). While the nef gene has been shown to be dispens- hyperacute disease in macaques (6).
Unlike studies on the env, only minimal emphasis hasable for virus replication in cell culture systems, inocula-
tion of adult macaques with SIVmac239 virus containing been placed on studies of the natural history of the nef
during prolonged infection in individual hosts. Sequencea deletion in the nef gene resulted in reduced virus loads
and attenuated virulence for adult macaques (7, 13). Re- analyses of the nef gene from HIV-1, HIV-2, and SIV iso-
lates have shown that this gene is heterogenous withcent evidence indicates that Nef down-regulates CD4
expression from the surface virus-infected cells (4, 9, 10). strong sequence conservation in the four blocks and in
the myristylation addition site at the amino terminus, inMolecular genetic studies have shown that amino acid
residues in the cytoplasmic domain of the CD4 molecule the region of acidic residues that was postulated to lie
on the external surface of the molecule, and a potentialare required for Nef-mediated endocytosis of CD4 (1, 8,
9). The down-regulation of surface CD4 by Nef appears recognition site for phosphorylation (R-T-M-S-Y-K) by
phosphokinase C (23). However, it is not known whetherto act through a common pathway since the endocytosis
of murine and human CD4 can be mediated by HIV-1 there is a preference for amino acid substitutions in cer-
tain regions of the protein or if there is a tissue-specificNef (3). Other studies have shown that Nef enhances
selection of nef variants with prolonged infection. This
can only be determined in animals inoculated with mo-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (913) 588-5599. lecularly cloned virus in which the nucleotide sequence
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FIG. 1. The predicted amino acid sequence of nef clones isolated from various tissues of macaques 10F, 13F, and 14F at necropsy. Br refers to
the frontal cortex, SC to spinal cord, LG to lung, IE to intestine, KD to kidney, and LN to lymph node as the tissue source of DNA for PCR amplification
and cloning. Shown above the sequences of the 74 clones is the sequence of SIVmac239 Nef protein (18). Dashes (-) represent amino acid identity
and * represents a stop codon.
of virus is known. Molecularly cloned SIVmac239 causes macaques infected with SIVmac , only minimal, randomly
distributed nucleotide substitutions were observed in nefpersistent infection and AIDS in most inoculated ma-
caques within 2 years (14). In 6- and 10-month studies of with no tissue-specific changes found (15, 19).
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FIG. 1—Continued
In this report, we analyzed nef gene sequences from env genes from different tissues has been described
previously and provided the basis of the present reportthree macaques (macaque 10F, 13F, and 14F) that had
been inoculated with molecularly cloned SIVmac239 and (12, 25). In that study, we showed that the gp120 region
of env isolated from the CNS of some macaques had amaintained for 89, 88, and 92 weeks, respectively. The
pathogenesis of the infection in the animals with respect very low nucleotide substitution rate when compared to
those isolated from lymph node tissue, whereas in otherto tissue tropism and nucleotide substitution rates of the
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as a template in a nested polymerase chain reactions
(PCR) to amplify the SIVmac nef gene. The oligonucleotide
primers used in the first round were 5*-CAGGACTGA-
ACTGACCTACCTACAATATGG-3* and 5*-ACATCCCCT-
TGTGGAAAGTCCCTGCTGTTT-3* (noncoding), which are
complementary to bases 9051 to 9080 and 9868 to 9898
of the SIVmac239 genome, respectively (18). One micro-
gram of genomic DNA was used in the PCR (20, 21)
containing 2.0 mM MgCl2 , 200 mM each of the four deoxy-
nucleotide triphosphates, 100 pM each oligonucleotide
primer, and 2.5 U of Taq polymerase (Perkin–Elmer–
Cetus, Norwalk, CT). The template was denatured at 927
for 3 min and PCR amplification performed with an auto-
mated DNA Thermal Cycler (Perkin–Elmer–Cetus) for 35
cycles using the following profile: denaturation at 927 for
1 min, annealing at 557 for 1 min, and primer extension
at 727 for 3 min. Amplification was completed by incuba-
tion of the PCR for 10 min at 727. One microliter of the
PCR product from above was used in a nested PCR using
the same reaction conditions described above. For the
second round of amplification, the nested set of primers
was 5*-ATGGGTGGAGCTATTTCCATGAGGCGGTCC-3*
and 5*-TCAGCGAGTTTCCTTCTTGTCAGCCAT-3* (non-
coding), which are complementary to bases 9077 to 9106
and 9842 to 9868 of the SIVmac239 genome, respectively.
The amplified nef gene products from three separate
PCRs were combined from each tissue and molecularly
cloned into the pGEM-T vector (Promega). Plasmids con-
taining nef gene sequences were sequenced by primer-
directed dideoxy sequencing using Sequenase enzyme
(U.S. Biochemicals, Cleveland, OH) and [35S]dATP. SIVmac
nef sequences were compared to the original SIVmac239
sequence using PCGENE sequence analysis software
programs.
The predicted amino acid sequences of the 74 nef
clones are shown in Fig. 1 and a summary of the genetic
changes in the genes isolated from macaques 10F, 13F,
and 14F are shown in Tables 1, 2, and 3, respectively.
No nucleotide deletions or insertions were observed in
any of the nef clones (Fig. 1). Only 5 of 74 clones (6.7%)
had premature termination codons. The substitution
rates of the nef clones varied among the three animals;
macaque 14F had the highest nucleotide substitution
rate (mean 2.45%) followed by macaques 13F and 10F,
which had nucleotide substitution rates of 1.69 and
1.53%, respectively (Tables 1, 2, and 3). The average
nucleotide and predicted amino acid substitution rates
FIG. 1—Continued also varied with each tissue of the infected macaques.
The average nucleotide substitution rate for macaque
10F ranged from 0.86% for clones derived from the CNSmacaques the nucleotide substitution rates between the
clones to 1.91% for nef clones derived from the intestine.two tissues were similar (25). In this study, we deter-
For macaque 13F, the average nucleotide substitutionmined whether the nef gene underwent variation at the
rates ranged from 1.45% for nef clones derived from thesame rate as env in different tissues. Total cellular geno-
lymph node to 2.1% for clones derived from lung tissue.mic DNA was extracted from one region of the central
For macaque 14F, the average nucleotide substitutionnervous system and three to four nonneural tissues (lung,
mesenteric lymph node, intestine, and kidney) and used rates ranged from 2.27% for nef clones derived from the
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TABLE 1
Genetic Changes in the nef Genes Isolated from Macaque 10F Compared to SIVmac239
Average Average Nucleotide
Total No. of Total No. of nucleotide amino acid substitutions
No. of clones nucleotides nucleotide substitution substitution leading to an amino
Tissue sequenced sequenced substitutions rate (%) rate (%) acid change (%)
CNSa 6 4752 41 0.86 2.47 88.10
Lung 6 4752 68 1.43 3.49 80.80
Intestine 6 4752 91 1.91 4.44 76.92
Kidney 5 3960 70 1.76 4.49 84.29
Lymph node 6 4752 82 1.73 4.06 78.05
Total 29 22,968 352 1.53 3.79 81.63
a Viral DNA was amplified from 10F frontal cortex tissue DNA.
lymph node tissue to 2.84% for clones derived from the played considerable variability (16.5% of the substitutions
but representing only 5.7% of the sequence), whereasCNS tissue. The observed variation in nef was not the
result of SIVmac239 replication in vitro since transfection residues 115–129 were highly conserved. While blocks
B and C (with the exception of a tyrosine to serine substi-of the genome and growth of the virus in macaque PBMC
for 1 week resulted in only one nucleotide change in the tution at position 167) were well conserved but the con-
servation of amino acids in block D appeared to be ani-two clones analyzed (a nucleotide substitution rate of
0.06%; data not shown). mal-specific, being conserved in macaque 13F but more
heterogenous in macaques 10F and 14F. Our resultsComparison of the predicted amino acid sequences
shown in Fig. 1 indicated that most of the amino acid revealed three additional conserved regions (amino
acids 1 to 10, 76 to 88, and 228 to 263) in the predictedheterogeneity (70%) was confined to 25 positions in four
regions comprising only 36% of the protein sequence. amino acid sequences from nef genes isolated from
these three animals. Collectively, amino acids 1 to 10,These included six amino acids from residues 39 to 75
(specifically, residues 39, 40, 41, 50, 63, and 75), seven 76 to 88, 115 to 153, 168 to 180, and 228 to 263 represent
42% of the protein sequence, but had only 5.0% of theamino acids from residues 90 to 105 (specifically, resi-
dues 90, 93, 96, 101, 102, 103, and 105), four amino acids observed amino acid substitutions in the nef genes se-
quenced (Figs. 1 and 2).from residues 153 to 167 (specifically, residues 153, 158,
161, and 167), eight amino acids from residues 191 to The results shown in Fig. 1 indicate an animal-specific
selection of nef genotypes from each of the three ma-217 (specifically, residues 191, 193, 195, 201, 204, 206,
212, and 217). In a previous study that compared the caques. For example, macaque 10F had an arginine to
lysine substitution at position 10 in all 29 clones, ma-amino acid sequences of HIV-1, HIV-2, and SIV Nef pro-
teins, four blocks of conserved amino acids were identi- caque 13F had a glycine to glutamic acid substitution at
position 63 in 24 of 25 clones, and macaque 14F had afied (23). These blocks included amino acid residues
from 95 to 129 (block A), 137 to 147 (block B), 164 to 182 tyrosine to serine substitution at position 39 in 18 of
20 clones examined. In addition, there were consensus(block C), and 209 to 220 (block D) (23). Our results indi-
cate that amino acid residues 95 to 114 of block A dis- amino acid substitutions observed among the nef clones
TABLE 2
Genetic Changes in the nef Genes Isolated from Macaque 13F Compared to SIVmac239
Average Average Nucleotide
Total No. of Total No. of nucleotide amino acid substitutions
No. of clones nucleotides nucleotide substitution substitution leading to an amino
Tissue sequenced sequenced substitutions rate (%) rate (%) acid change (%)
CNSa 6 4752 74 1.76 4.69 88.10
Lung 5 3960 83 2.10 5.02 79.52
Intestine 4 3168 51 1.61 4.47 92.16
Kidney 4 3168 58 1.83 4.66 87.93
Lymph node 6 4752 69 1.45 4.00 91.30
Total 25 19,800 335 1.69 4.57 87.80
a Viral DNA was amplified from 13F frontal cortex tissue DNA.
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TABLE 3
Genetic Changes in the nef Genes Isolated from Macaque 14F Compared to SIVmac239
Average Average Nucleotide
Total No. of Total No. of nucleotide amino acid substitutions
No. of clones nucleotides nucleotide substitution substitution leading to an amino
Tissue sequenced sequenced substitutions rate (%) rate (%) acid change (%)
CNSa 6 4752 135 2.84 6.27 84.44
Lung 4 3168 75 2.37 5.70 86.67
Kidney 5 3960 88 2.22 5.25 85.23
Lymph node 5 3960 90 2.27 5.32 85.56
Total 20 15,840 388 2.45 5.64 85.48
a Viral DNA was amplified from 14F spinal cord tissue DNA.
from two of three macaques. For example, the leucine tions. Of the 14 tissues analyzed from these three ani-
mals, tissue-specific selection of nef variants were notto serine substitution at position 50, the isoleucine to
glutamic acid substitution at position 153, and the tyro- observed except for those clones isolated from macaque
10F brain. Clones isolated from macaque 10F brain allsine to phenylalanine substitution at position 167 was
observed in both macaques 13F and 14F. The finding of had a tyrosine to cysteine substitution at position 193
and a proline to threonine substitution at position 206.the same amino acid substitutions in more than one ani-
mal suggests a nonrandom occurrence of these substitu- Alignment of the predicted Nef sequences from macaque
FIG. 2. Schematic diagram of the number of amino acid substitutions at each site for all nef clones isolated from macaques 10F (A), 13F (B), and
14F (C). For comparative purposes, solid bars have been placed over conserved blocks of amino acids previously identified by Shugars et al. (23).
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TABLE 4 or env gene products. The structure of the nef gene in
SIVmac239 overlaps the gp41 region of the env gene byMost Frequent Amino Acid Substitutions from the nef Genes
163 bases or 20.6% of the gene (18). Analysis showedIsolated from Macaque 10F, 13F, and 14F
that a total of 221 nucleotide substitutions (20.6% of the
No. positive/total total substitutions) in the 74 nef clones occurred in this
Amino acid Amino acid No. clones region of overlap (Table 6). Approximately 82.6% of the
Animal position substitution sequenced
221 nucleotide substitutions led to an amino acid change
in nef gene product. Correspondingly, only 26.0% of the10F 12 R r K 29/29
41 Q r R/L 21/29 nucleotide substitutions in the region of overlap with env
90 I r V 16/29 led to an amino acid change in gp41. Only about 9.5%
93 Ter. r E/K 29/29 of substitutions in this region led to an amino acid
96 D r V/G/E 19/29
change in both gp41 and Nef. These results indicated a102 V r M/I 15/29
preference for the selection of variants with amino acid204 D r N 17/29
13F 50 L r S 15/25 substitutions in Nef versus the gp41 in this region.
63 G r E 24/25 There are several points that suggest that the nef
75 E r K/G 13/25 genes analyzed in this study arose from actively replicat-
93 Ter. r E 25/25
ing virus and were part of an evolutionary process. First,103 R r K 13/25
there was a reversion of the premature termination codon153 I r V 22/25
158 D r E 25/25 at position 93 to a glutamic acid in every nef clone ana-
161 S r L 14/25 lyzed. If the nef genes analyzed were from defective vi-
167 Y r F 24/25 ruses, there would not have been selective pressure to
193 Y r C 13/25
revert this termination codon to one coding for an amino14F 39 Y r S 18/20
acid. Second, if the amplified products were from defec-50 L r S 11/20
75 E r T/V 20/20 tive viruses (and hence unable to replicate and spread),
93 Ter. r E 20/20 one would expect these viruses to be localized in the
103 R r M/T/N/K 17/20 tissue that they were derived. However, our results indi-
105 K r R 13/20
cate that the majority of the observed nucleotide substitu-158 D r E 13/20
tions (and predicted amino acid substitutions) were ob-167 Y r F 20/20
191 E r R/K/G 10/20 served in nef genes amplified from multiple tissues.
201 S r Y 16/20 Third, nef genes with similar sequence were amplified
212 A r V 12/20 from multiple PCRs (three used for each tissue), sug-
217 P r S 13/20
gesting that they were the predominant nef quasispecies227 V r I 13/20
in these tissues.
In summary, we have shown that following inoculation
of macaques with SIVmac239, each animal selected vari-
10F also showed that the sequences isolated from the ants with substitutions targeted to specific amino acid
brain clustered together (data not shown). The most fre- residues. Most of the variation (70% of the amino acid
quent amino acid substitutions occurring in the nef genes changes) was confined to four specific regions of the nef
from each of the three macaques are listed in Table 4. gene comprising only 36% of the protein. The rate of
We compared the nucleotide and amino acid substitu-
tion rates sequences of the nef gene isolated from CNS
TABLE 5and lymphoid tissues with the gp120 genes isolated from
the same tissues and published previously (25). The re- Comparison of Genetic Changes in the env (gp120) and nef Genes
Isolated from Macaque 10F, 13F, and 14Fsults of this comparison are summarized in Table 5. The
results indicated that the nucleotide and amino acid sub-
Averagestitution rates of the nef genes isolated from one animal
nucleotide Average amino
(14F) were significantly higher than the gp120 genes de- substitution acid substitution
rived from both brain and the lymph node tissue, while rate (%) rate (%)
in the other two animals, 10F and 13F, the nucleotide
Tissue Animal env nef gp120 Nefand amino acid substitution rates were slightly higher in
nef genes than the gp120 genes derived from CNS but CNS 10F 0.40 0.86 1.18 2.47
were very similar from lymphoid tissues. 13F 1.46 1.76 3.70 4.69
We examined the nucleotide substitutions in the region 14F 0.51 2.84 0.99 6.27
LN 10F 1.68 1.73 4.48 4.06of the nef that overlaps with the gp41 region of env to
13F 1.19 1.45 4.0 4.0determine if their was a preference for the selection of
14F 1.28 2.27 3.0 5.32
variants with amino acid substitutions in either the nef
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TABLE 6
Analysis of the Nucleotide Substitutions That Overlap the env and nef Genes
Rate of nucleotide Rate of nucleotide Rate of nucleotide
Total nucleotide substitutions substitutions substitutions
No. of nef clones substitutions in leading to Nef leading to gp41 leading to an a.a.
Animal sequenced overlap region a.a. change (%) a.a. change (%) change in both (%)
10F 29 86 90.70 12.79 4.65
13F 25 67 77.61 34.33 11.94
14F 20 68 79.41 30.88 11.76
Total 74 221 82.57 26.00 9.45
11. Harris, M. P. G., and Neil, J. C., J. Mol. Biol. 241, 136–142 (1994).nucleotide and amino acid variation was comparable to
12. Joag, S. V., Stephens, E. B., Adams, R. J., Foresman, L., and Narayan,and in some cases exceeded the observed variation for
O., Virology 200, 436–446 (1994).
the gp120 region of the env gene. However, while it ap- 13. Kestler III, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal,
pears that tissue-specific selection of virus variants oc- P. K., Daniel, M. D., and Desrosiers, R. C., Cell 65, 651–662
(1991).curs in the env gene (15, 25, 26), tissue-specific selection
14. Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N.,of nef genotypes was less prevalent.
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